Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Galera Therapeutics, Inc. (GRTX) had Pre-Tax Income of $153.10M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$153.10M |
|
-- |
|
-- |
|
$-1.99M |
|
$1.99M |
|
$151.11M |
|
|
Pre-Tax Income |
$153.10M |
$153.10M |
|
$153.10M |
|
$153.10M |
|
$153.10M |
|
$153.10M |
|
$1.99M |
|
$1.99M |
|
98.50M |
|
98.50M |
|
$0.66 |
|
$0.66 |
|
| Balance Sheet Financials | |
$7.09M |
|
-- |
|
$0.10M |
|
$7.20M |
|
$0.65M |
|
-- |
|
$2.58M |
|
$3.22M |
|
$3.97M |
|
$3.97M |
|
$3.97M |
|
75.46M |
|
| Cash Flow Statement Financials | |
$-6.05M |
|
$3.50M |
|
$0.64M |
|
$8.29M |
|
$6.38M |
|
$-1.91M |
|
$0.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.05M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
3852.61% |
|
3852.64% |
|
2127.63% |
|
3852.64% |
|
$0.05 |
|
$-0.06 |
|
$-0.06 |
|